Rothschild Redburn initiates Apogee stock with buy on AD therapy
Corroborated by 2 sources from 2 publishers
TL;DR
Reports differ across sources; according to investing.com, rothschild Redburn initiates Apogee stock with buy on AD therapy.
Sources
1
Investing.com News
https://www.investing.com/news/analyst-ratings/rothschild-redburn-initiates-apogee-stock-with-buy-on-ad-therapy-93CH-4652067
2
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/rothschild-co-redburn-downgrades-insulet-080025995.html
3
Investing.com News
https://www.investing.com/news/analyst-ratings/rothschild-redburn-initiates-coherent-stock-with-buy-on-ai-demand-93CH-4652076
4
Investing.com News
https://www.investing.com/news/analyst-ratings/rothschild-redburn-initiates-lumentum-stock-with-buy-on-laser-demand-93CH-4652077
5
Investing.com News
https://www.investing.com/news/analyst-ratings/rothschild-redburn-initiates-ciena-stock-with-neutral-rating-93CH-4652080
6
Investing.com News
https://www.investing.com/news/analyst-ratings/rothschild-redburn-initiates-astera-labs-stock-with-neutral-rating-93CH-4652081
7
Investing.com News
https://www.investing.com/news/analyst-ratings/rothschild-redburn-initiates-credo-technology-stock-with-buy-rating-93CH-4652082
8
Investing.com News
https://www.investing.com/news/analyst-ratings/rothschild-redburn-initiates-celestica-stock-with-buy-on-ai-growth-93CH-4652084